Septerna, Inc. (SEPN): Total Asset Value of Company
Septerna Inc (SEPN) brings together leading cell receptor researchers, attracting talent through cutting-edge technologies and high compensation. The company's innovative targeted therapy platform allows it to lead in immunology, outpacing less developed players. The market capitalization trend indicates that total assets amount to 490.69. Drug development is not subject to seasonality or cycles, relying instead on patent terms, although it remains sensitive to market liquidity.
Comprehensive metric breakdowns and analytics for Septerna Corp (SEPN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:SEPN, septerna.com
For the biotech startup Septerna Inc (SEPN) with its Native GPCR platform, total assets represent the aggregate resource base required to advance oral medications into clinical phases. This calculation of assets and resources, reverse-engineered via ROA, allows investors to track capital efficiency following the IPO and assess the company's financial stability while scaling within a behemoth addressable market.
Competitors of Septerna Inc (SEPN)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|PVLA: Company Total Assets|Savara Inc - Company Assets|Aggregate Company Assets RIGL (Rigel Pharmaceuticals Inc)|ANAB - Company Total Asset Base|Company Total Assets ATXS|ENGN (engene.com) - Company Assets|Aggregate Company Assets RAPT Therapeutics RAPT|Total Asset Value of Company Aerovate (JBIO)|Cumulative Company Assets Aclaris|Aggregate Business Assets Kyverna Therapeutics, Inc (KYTX)|TLSA: Company Total Assets|cabalettabio.com - Company Assets|Aggregate Company Assets Ventyx Biosciences, Inc. (VTYX)|THTX: Aggregate Asset Value|Aggregate Company Assets Avalo Therapeutics Inc.|Eledon Pharmaceuticals, Inc (ELDN) - Total Business Assets|AGEN (Agenus) - Company Total Assets|Company Total Assets climbbio.com (CLYM)|Zura Bio (ZURA) - Cumulative Company Assets|Aggregate Asset Value aTyr Pharma Inc (ATYR)|Company Total Assets ADAG|ImageneBio - Company Total Asset Base|Shattuck Therapeutics (STTK) - Aggregate Company Assets|EQ - Total Business Assets|CNTB (connectbiopharm.com) - Company Total Assets|IMUX (Immunic) - Cumulative Company Assets|ATRA: Aggregate Company Assets|Company Total Asset Base InflaRx GmbH|X4 Pharmaceuticals - Company Total Assets|Company Assets ACET (adicetbio.com)|Celularity (CELU) - Aggregate Company Assets|INmune Bio Inc - Total Asset Value of Company|Barinthus Bio (BRNS) - Aggregate Company Assets|KZR: Total Business Assets|Aggregate Company Assets SAB Biotherapeutics (SABS)|akaritx.com (AKTX) - Total Asset Value of Company|ENLV - Company Total Assets|Aggregate Asset Value Q32 Bio Corp|Company Total Assets GOVX|Company Total Assets EDSA (Edesa Biotech Corp)|Aggregate Company Assets iBio, Inc.|Carisma Therapeutics Inc - Aggregate Asset Value|XTLB: Aggregate Company Assets|BOLT - Cumulative Company Assets|HCWB: Company Total Assets|Company Total Assets Aptevo Therapeutics Inc.|AIM - Cumulative Company Assets|Aggregate Asset Value Aditxt Corp|GRI (GRI Bio) - Company Total Assets|Company Total Asset Base XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|Revelation Biosciences Corp - Cumulative Company Assets|INDP: Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI: Cumulative Company Assets|AFMD (Affimed N.V.) - Company Total Assets|Aggregate Company Assets Allakos Inc (ALLK)|Total Business Assets HOOKIPA|IGM Biosciences, Inc. - Company Total Assets|Company Assets ITOS (iteostherapeutics.com)|Aggregate Company Assets OCEA|Company Total Asset Base TC BioPharm (Holdings) Plc TCBP|THRD (Third Harmonic Bio, Inc) - Company Total Assets